[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Bo Feldt-Rasmussen\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100568030","continuous-glucose-monitoring-cgm-after-kidney-transplantation-100568030",false,"NCT06675903","Continuous Glucose Monitoring (CGM) After Kidney Transplantation","Continuous Glucose Monitoring in Kidney Transplant Recipients with Diabetes, Pre-diabetes and Without Diabetes","CGM-KTx","Inclusion Criteria:\n\n* Written informed consent obtained before CGM application\n* Male or female; age: ≥18 years\n* Kidney transplantation\n\nExclusion Criteria:\n\n* Unable to cooperate to CGM the first ten days after surgery\n* Allergic to plasters in CGM units\n* Combined kidney and liver or pancreatic transplantation\n* Graft loss\u002Frejection within first 48 hours after transplantation","ALL","18 Years",{"count":20,"type":21},54,"ESTIMATED","OBSERVATIONAL","This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes.\n\nThe primary objective is to analyse differences in mean sensor glucose between these three groups.\n\nCGMs are applied to participants within 72 hours after kidney transplantation, with a total of 54 participants divided equally across the three groups (18 in each).\n\nSecondary objectives include assessing additional glucose profile indices, adherence to relevant guidelines, changes in HbA1c, the impact of immunosuppression and steroid dosage, and beta cell function.",[25,26],"Hyperglycaemia","Kidney Transplantation",[28,29,30,31,32,33],"Kidney transplantation","diabetes","prediabetes","hyperglycaemia","continuous glucose monitoring","CGM","RECRUITING","2024-11-12",{"date":37,"type":38},"2024-11-13","ACTUAL",{"date":35,"type":38},{"date":41,"type":21},"2026-01-01",{"name":43,"class":44},"Bo Feldt-Rasmussen","OTHER",""]